Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/29/24
End: 09/01/28
Due: 09/01/29
Phase: N/A
Priority: Normal
Start: 03/14/16
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 04/19/20
End: 01/31/25
Due: 01/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study | NCT06377852 | American Society of Clinical Oncology | user2@example.com | None | 2024-10-29 | 2028-09-01 | 2029-09-01 | - | - | 2025-07-14 |
| TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer | NCT02693535 | American Society of Clinical Oncology | user2@example.com | None | 2016-03-14 | 2028-12-31 | 2029-12-31 | - | - | 2025-07-14 |
| ASCO Survey on COVID-19 in Oncology (ASCO) Registry | NCT04659135 | American Society of Clinical Oncology | user2@example.com | None | 2020-04-19 | 2025-01-31 | 2026-01-31 | - | - | 2025-07-14 |